Docetaxel extravasation: Pathologic correlation and treatment with intralesional steroids
JAAD Case Rep
.
2017 Jul 18;3(4):322-325.
doi: 10.1016/j.jdcr.2017.04.013.
eCollection 2017 Jul.
Authors
John W Roman
1
,
Michelle A Ojemuyiwa
2
,
Lisa M Cordes
3
,
Ravi A Madan
4
,
Leonard Sperling
5
Affiliations
1
Department of Dermatology, Walter Reed National Military Medical Center, Bethesda, Maryland.
2
Department of Hematology/Oncology, Walter Reed National Military Medical Center, Bethesda, Maryland.
3
National Institutes of Health, Clinical Center Pharmacy Department, Bethesda, Maryland.
4
Genitourinary Malignancies Branch, Center for Cancer Research, National Cancer Institute, Bethesda, Maryland.
5
Department of Dermatology and Pathology, Uniformed Services University of the Health Sciences, Bethesda, Maryland.
PMID:
28752121
PMCID:
PMC5518152
DOI:
10.1016/j.jdcr.2017.04.013
No abstract available
Keywords:
docetaxel; extravasation; intralesional steroids; pathology; prostate cancer treatment.
Publication types
Case Reports